Vaccines Market Report

Global Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：184
  • REPORT CODE：GMM851579
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Vaccines market report explains the definition, types, applications, major countries, and major players of the Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Kangtai

    • Sanofi

    • Hissen

    • China National Biotec

    • Pfizer

    • Hualan

    • GSK

    • Jintan

    • Novartis(Kangtai)

    • CSL

    • Novartis(GSK)

    • Tiantan

    • Merck

    • MedImmune LLC

    By Type:

    • Live Attenuated Vaccine

    • Inactivated Vaccines

    • Subunit Vaccine

    • Recombinant Vaccines

    • Nucleic Acid Vaccine

    • Other

    By End-User:

    • Children

    • Adults

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Vaccines Market- Recent Developments

    • 6.1 Vaccines Market News and Developments

    • 6.2 Vaccines Market Deals Landscape

    7 Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Vaccines Key Raw Materials

    • 7.2 Vaccines Price Trend of Key Raw Materials

    • 7.3 Vaccines Key Suppliers of Raw Materials

    • 7.4 Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Vaccines Cost Structure Analysis

      • 7.5.1 Vaccines Raw Materials Analysis

      • 7.5.2 Vaccines Labor Cost Analysis

      • 7.5.3 Vaccines Manufacturing Expenses Analysis

    8 Global Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Live Attenuated Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Inactivated Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Subunit Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Recombinant Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Nucleic Acid Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adults Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Vaccines Consumption (2017-2022)

      • 10.3.2 UK Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Vaccines Consumption (2017-2022)

      • 10.3.5 France Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Vaccines Consumption (2017-2022)

      • 10.4.3 India Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Vaccines Consumption (2017-2022)

    11 Global Vaccines Competitive Analysis

    • 11.1 Kangtai

      • 11.1.1 Kangtai Company Details

      • 11.1.2 Kangtai Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Kangtai Vaccines Main Business and Markets Served

      • 11.1.4 Kangtai Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Details

      • 11.2.2 Sanofi Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi Vaccines Main Business and Markets Served

      • 11.2.4 Sanofi Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Hissen

      • 11.3.1 Hissen Company Details

      • 11.3.2 Hissen Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Hissen Vaccines Main Business and Markets Served

      • 11.3.4 Hissen Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 China National Biotec

      • 11.4.1 China National Biotec Company Details

      • 11.4.2 China National Biotec Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 China National Biotec Vaccines Main Business and Markets Served

      • 11.4.4 China National Biotec Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Pfizer

      • 11.5.1 Pfizer Company Details

      • 11.5.2 Pfizer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Pfizer Vaccines Main Business and Markets Served

      • 11.5.4 Pfizer Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Hualan

      • 11.6.1 Hualan Company Details

      • 11.6.2 Hualan Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Hualan Vaccines Main Business and Markets Served

      • 11.6.4 Hualan Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 GSK

      • 11.7.1 GSK Company Details

      • 11.7.2 GSK Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 GSK Vaccines Main Business and Markets Served

      • 11.7.4 GSK Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Jintan

      • 11.8.1 Jintan Company Details

      • 11.8.2 Jintan Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Jintan Vaccines Main Business and Markets Served

      • 11.8.4 Jintan Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Novartis(Kangtai)

      • 11.9.1 Novartis(Kangtai) Company Details

      • 11.9.2 Novartis(Kangtai) Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Novartis(Kangtai) Vaccines Main Business and Markets Served

      • 11.9.4 Novartis(Kangtai) Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 CSL

      • 11.10.1 CSL Company Details

      • 11.10.2 CSL Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 CSL Vaccines Main Business and Markets Served

      • 11.10.4 CSL Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Novartis(GSK)

      • 11.11.1 Novartis(GSK) Company Details

      • 11.11.2 Novartis(GSK) Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Novartis(GSK) Vaccines Main Business and Markets Served

      • 11.11.4 Novartis(GSK) Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Tiantan

      • 11.12.1 Tiantan Company Details

      • 11.12.2 Tiantan Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Tiantan Vaccines Main Business and Markets Served

      • 11.12.4 Tiantan Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Merck

      • 11.13.1 Merck Company Details

      • 11.13.2 Merck Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Merck Vaccines Main Business and Markets Served

      • 11.13.4 Merck Vaccines Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 MedImmune LLC

      • 11.14.1 MedImmune LLC Company Details

      • 11.14.2 MedImmune LLC Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 MedImmune LLC Vaccines Main Business and Markets Served

      • 11.14.4 MedImmune LLC Vaccines Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Live Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Inactivated Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Subunit Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Nucleic Acid Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Vaccines

    • Figure of Vaccines Picture

    • Table Global Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Live Attenuated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Inactivated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Subunit Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Nucleic Acid Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption by Country (2017-2022)

    • Table North America Vaccines Consumption by Country (2017-2022)

    • Figure United States Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Vaccines Consumption by Country (2017-2022)

    • Figure Germany Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Vaccines Consumption by Country (2017-2022)

    • Figure China Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Vaccines Consumption by Country (2017-2022)

    • Figure Australia Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Vaccines Consumption and Growth Rate (2017-2022)

    • Table Kangtai Company Details

    • Table Kangtai Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kangtai Vaccines Main Business and Markets Served

    • Table Kangtai Vaccines Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Vaccines Main Business and Markets Served

    • Table Sanofi Vaccines Product Portfolio

    • Table Hissen Company Details

    • Table Hissen Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hissen Vaccines Main Business and Markets Served

    • Table Hissen Vaccines Product Portfolio

    • Table China National Biotec Company Details

    • Table China National Biotec Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table China National Biotec Vaccines Main Business and Markets Served

    • Table China National Biotec Vaccines Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Vaccines Main Business and Markets Served

    • Table Pfizer Vaccines Product Portfolio

    • Table Hualan Company Details

    • Table Hualan Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Vaccines Main Business and Markets Served

    • Table Hualan Vaccines Product Portfolio

    • Table GSK Company Details

    • Table GSK Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Vaccines Main Business and Markets Served

    • Table GSK Vaccines Product Portfolio

    • Table Jintan Company Details

    • Table Jintan Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jintan Vaccines Main Business and Markets Served

    • Table Jintan Vaccines Product Portfolio

    • Table Novartis(Kangtai) Company Details

    • Table Novartis(Kangtai) Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis(Kangtai) Vaccines Main Business and Markets Served

    • Table Novartis(Kangtai) Vaccines Product Portfolio

    • Table CSL Company Details

    • Table CSL Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Vaccines Main Business and Markets Served

    • Table CSL Vaccines Product Portfolio

    • Table Novartis(GSK) Company Details

    • Table Novartis(GSK) Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis(GSK) Vaccines Main Business and Markets Served

    • Table Novartis(GSK) Vaccines Product Portfolio

    • Table Tiantan Company Details

    • Table Tiantan Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiantan Vaccines Main Business and Markets Served

    • Table Tiantan Vaccines Product Portfolio

    • Table Merck Company Details

    • Table Merck Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Vaccines Main Business and Markets Served

    • Table Merck Vaccines Product Portfolio

    • Table MedImmune LLC Company Details

    • Table MedImmune LLC Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune LLC Vaccines Main Business and Markets Served

    • Table MedImmune LLC Vaccines Product Portfolio

    • Figure Global Live Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inactivated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subunit Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nucleic Acid Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US